RETINAL DYSTROPHY
Clinical trials for RETINAL DYSTROPHY explained in plain language.
Never miss a new study
Get alerted when new RETINAL DYSTROPHY trials appear
Sign up with your email to follow new studies for RETINAL DYSTROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Common diabetes pill could be key to slowing rare blindness
Disease control Recruiting nowThis study is testing if the oral diabetes medication metformin is safe and can slow down the progression of ABCA4 retinopathy, a genetic eye disease that causes vision loss. It will involve about 56 participants aged 12 and older who have the disease. Participants will take metf…
Matched conditions: RETINAL DYSTROPHY
Phase: PHASE1, PHASE2 • Sponsor: National Eye Institute (NEI) • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
Gene therapy injection tested to halt vision loss in rare eye disease
Disease control Recruiting nowThis early-stage study is testing a new gene therapy called LX107 for people with a rare inherited eye disease that causes vision loss. Doctors will inject the therapy directly into the retina of one eye in up to 13 patients to see if it is safe and if it can improve or stabilize…
Matched conditions: RETINAL DYSTROPHY
Phase: EARLY_PHASE1 • Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Mar 19, 2026 14:55 UTC